Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2026-06-03 Major Shareholding Noti…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Change in substantial holding from Tiga Trading Pty Ltd 4 pages 105.3KB
Major Shareholding Notification Classification · 95% confidence The document is an ASX Form 604 “Notice of change of interests of substantial holder” under section 671B of the Corporations Act, detailing dilution in voting power, changes in relevant interests and associates. This is a notification of a change in a major shareholding, matching the “Major Shareholding Notification” category.
2026-06-03 English
Implementation of Merger between LGP and Cannatrek 5 pages 261.0KB
M&A Activity Classification · 85% confidence The document is an ASX announcement describing the successful implementation of a scheme of arrangement under which Little Green Pharma acquires 100% of Cannatrek (a merger transaction). It details the merger rationale, scheme implementation, changes in share capital, board composition changes, retirements, incoming directors, and related remuneration adjustments—all hallmarks of a Merger & Acquisition announcement. It is not a formal annual or interim report, nor a simple report publication notice, but rather a transaction announcement. Therefore it falls under M&A Activity (TAR).
2026-06-01 English
Application for quotation of securities - LGP 6 pages 18.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 2A form submitted to the ASX requesting quotation (listing) of newly issued securities following a transaction (a Scheme). It provides details about the type, number, and consideration for the new securities, as well as post-issuance capital structure. This is clearly a share issue/capital change announcement, matching code SHA.
2026-06-01 English
Notification regarding unquoted securities - LGP 6 pages 19.9KB
Share Issue/Capital Change Classification · 88% confidence The document is an ASX Appendix 3G form notifying the issue, conversion, or payment up of unquoted equity securities. It provides details of a new class of convertible share rights and the numbers issued, clearly making it a share issuance/capital change announcement. Therefore, it fits the "Share Issue/Capital Change (SHA)" category.
2026-06-01 English
Application for quotation of securities - LGP 6 pages 19.0KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 2A application for quotation of securities, detailing the conversion of options/share rights into new fully paid ordinary shares and the subsequent listing of those shares. This is an announcement of a new share issue and capital change, matching the Share Issue/Capital Change category.
2026-06-01 English
Application for quotation of securities - LGP 6 pages 18.4KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 2A “Application for quotation of securities” by Little Green Pharma detailing the issue and quotation of 165,605 ordinary shares following option conversions. It announces a new share issue/capital change. This corresponds directly to “Share Issue/Capital Change (SHA).” It is not merely a report publication nor a broader regulatory filing.
2026-06-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.